| 1631 |
ARIMIDEX ANAR |
ANASTROZOLE 1 MG |
TABLET |
BLISTERPACK |
TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER, ADJUVANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE EARLY BREAST CANCER, TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOW TAMOXIFEN THERAPY |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
07 L 1131/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
| 1632 |
AVASTATIN |
ATORVASTATIN 20 MG |
TABLET |
BLISTERPACK |
HYPERCHOLESTEROLEMIA, PRIMARY HYPERCHOLESTEROLEMIA, CORONARY HEART DISEASE, COMPLEX DYSLIPIDEMIA. |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
12 L 1050/23 |
15-JAN-2024 |
14-JAN-2027 |
View |
| 1633 |
BARINIX-2 |
BARICITINIB 2 MG |
TABLET |
BOTTLE |
RHEUMATOID ARTHRITIS, 2019 coronavirus (COVID-19), ALOPECIA AREATA |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
11 L 1231/24 |
14-NOV-2024 |
13-NOV-2029 |
View |
| 1634 |
BARINIX-4 |
BARICITINIB 4 MG |
TABLET |
BOTTLE |
RHEUMATOID ARTHRITIS, ALOPECIA AREATA |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
11 L 1232/24 |
14-NOV-2024 |
13-NOV-2029 |
View |
| 1635 |
BEDAQUIS |
BEDAQUILLINE FUMARATE 100 MG |
TABLET |
BOTTLE |
AS PART OF COMBINATION THERAPY IN ADULTS (>= 18 YEARS) WITH PULMONARY MULTI-DRUG-REISITANT TUBERCULOSIS (MDR-TB) |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
03 L 1310/25 |
31-MAR-2025 |
30-MAR-2030 |
View |
| 1636 |
BEMPEDIS |
BEMPEDOLE ACID 180 MG |
TABLET |
BOTTLE |
AS AN ADJUNCT TO DIET AND MAXIMALLY TOLERATE STATIN THERAPY FOR THE TREATEMNT OF ADULT WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA OR ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WHO REQUIRE ADDITIONAL LOWERING OF LDC-C |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
03 L 1308/25 |
31-MAR-2025 |
30-MAR-2030 |
View |
| 1637 |
BENRAMINE |
CHLORPHENIRAMINE MALEATE 4 MG |
TABLET |
BLISTERPACK |
ANTIHISTAMINE |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
03 L 1078/24 |
14-MAR-2024 |
13-MAR-2027 |
View |
| 1638 |
BRIGANIE |
BRIGATINIB 90 MG |
TABLET |
BOTTLE |
TREATMEN OF ADULT PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE -POSITIVE METASTATIC NON SMALL CELL LUNG CANCER |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
03 L 0954/23 |
07-APR-2025 |
06-APR-2030 |
View |
| 1639 |
C-500 ALLI |
VITAMINC 500 MG |
TABLET |
BOTTLE |
TREATMENT AND PREVENTION OF SCURVY (VITAMIN C DEFICIENCY) |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
10 L 0929/22 |
11-Nov-2022 |
10-Nov-2025 |
View |
| 1640 |
C-500 ALLI |
VITAMINC 500 MG |
TABLET |
BLISTERPACK |
TREATMENT AND PREVENTION OF SCURVY (VITAMIN C DEFICIENCY) |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
10 L 0928/22 |
11-Nov-2022 |
10-Nov-2025 |
View |
